The irreversible HCV-associated risk of gastric cancer following interferon-based therapy: a joint study of hospital-based cases and nationwide population-based cohorts.

Chen, Chun-Wei; Cheng, Jur-Shan; Chen, Tai-Di; Le, Puo-Hsien; Ku, Hsin-Ping; Chang, Ming-Ling

Chen, Chun-Wei; Cheng, Jur-Shan; Chen, Tai-Di; Le, Puo-Hsien; Ku, Hsin-Ping; Chang, Ming-Ling.

Afiliación

Chen CW; Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
Cheng JS; Clinical Informatics and Medical Statistics Research Center, Chang Gung University, Taoyuan, Taiwan.
Chen TD; Department of Anatomic Pathology, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
Le PH; Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
Ku HP; Clinical Informatics and Medical Statistics Research Center, Chang Gung University, Taoyuan, Taiwan.
Chang ML; Liver Research Center, Division of Hepatology, Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, No 5, Fu Hsing Street, Kuei Shan, Taoyuan, 33305, Taiwan.

Therap Adv Gastroenterol ; 12: 1756284819855732, 2019.

Article en En | MEDLINE | ID: mdl-31244896

Palabras clave

HCV; age; gastric cancer; sex

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Therap Adv Gastroenterol Año: 2019 Tipo del documento: Article País de afiliación: Taiwán

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google